Blood Gas and Electrolyte Analyzers Market Report 2026

The blood gas and electrolyte analyzers market size has grown strongly in recent years. It will grow from $3.65 billion in 2025 to $3.98 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing critical care admissions, expansion of hospital laboratory infrastructure, growing use of arterial blood gas testing, rising prevalence of respiratory disorders, wider availability of automated analyzers.

The blood gas and electrolyte analyzers market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for decentralized diagnostics, rising focus on emergency and intensive care testing, expansion of home and near-patient testing models, growing investments in smart diagnostic devices, increasing adoption of integrated laboratory workflows. Major trends in the forecast period include increasing adoption of point-of-care blood gas testing, rising demand for portable and benchtop analyzers, growing integration of multi-parameter testing platforms, expansion of cartridge-based consumable usage, enhanced focus on rapid turnaround diagnostics.

The rising number of patients has led to an increase in blood sample testing, driving the growth of the blood gas and electrolyte analyzers market. Blood tests serve multiple purposes, including assessing cholesterol and blood glucose levels. These tests help monitor the risk of heart disease, vascular disorders, and diabetes, as well as evaluate the effectiveness of ongoing treatments. For example, in June 2024, the Royal College of General Practitioners, a UK-based professional membership organization, reported that the average number of patients per GP rose from 2,222 in 2022 to 2,294 in April 2024, reflecting an increasing demand for general practitioner services. Consequently, the rise in patient numbers has led to more blood sample testing, contributing to the expansion of the blood gas and electrolyte analyzers market.

Leading companies in the blood gas and electrolyte analyzers market are concentrating on creating innovative solutions, such as advanced automated analyzer systems, to address the growing need for rapid, accurate, and comprehensive blood parameter testing in clinical settings. Advanced automated analyzers combine multiple detection technologies, including ion-selective electrodes, impedance measurement, and amperometry, to provide fast and reliable results, offering a more efficient alternative to traditional manual or semi-automated testing methods. For instance, in June 2024, Sensa Core, an India-based company in the blood gas and electrolyte analyzer sector, introduced the ST-200 CC Ultra Smart Blood Gas Analyzer for hospitals and diagnostic centers. This fully automated system employs ISE (Ion Selective Electrode), Impedance (Hct), and Amperometry (pO₂) technologies to analyze arterial blood gases and electrolytes. It measures parameters such as sodium, potassium, ionized calcium, pH, hematocrit, oxygen, carbon dioxide, and more, providing 27 results from a single blood sample. The analyzer also includes an internal barcode scanner and multiple external interfaces to optimize workflow and improve usability.

In May 2024, Radiometer A/S, a Denmark-based medical device company, formed a partnership with Etiometry, Inc. to incorporate advanced clinical decision-support capabilities into its diagnostic solutions. Through this collaboration, Radiometer plans to integrate its blood gas and electrolyte measurement devices with Etiometry’s clinical intelligence platform, allowing real-time risk analytics and workflow optimization in intensive care units. Etiometry, Inc. offers artificial intelligence-driven predictive insights by compiling patient data from various sources to aid timely clinical decision-making and enhance patient outcomes. Etiometry, Inc. is a U.S.-based clinical decision support and data analytics company focused on predictive analytics and real-time patient monitoring for intensive care units (ICUs).

Major companies operating in the blood gas and electrolyte analyzers market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers AG, Werfen, Abbott Laboratories, Medica Corporation, EDAN Instruments Inc, Radiometer Medical, Nova Biomedical, OPTI Medical systems Inc, I Sens Inc, JOKOH CO. LTD, Prolong Medical Equipment Co. Ltd, Sensa Core Medical Instrumentation Pvt. Ltd, Hunan Rainbow Technology Co. Ltd, ERBA Mannheim, EKF Diagnostics, Grifols, Vygon SAS, Biofidus, KwertyMed, Instrumentation Laboratory Company, Becton Dickinson and Co, Microbiology E.A Ltd.

North America was the largest region in the blood gas and electrolyte analyzers market in 2025 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the blood gas and electrolyte analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood gas and electrolyte analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the blood gas and electrolyte analyzers market by increasing costs of imported sensors, electrodes, cartridges, electronic components, and precision analyzers used in portable and laboratory systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported diagnostic equipment, while Asia-Pacific faces cost pressure on analyzer manufacturing and exports. These tariffs are raising procurement and maintenance costs and slowing replacement cycles. However, they are also encouraging localized manufacturing, regional supplier diversification, and increased focus on cost-optimized analyzer designs and consumables.

The blood gas and electrolyte analyzers market research report is one of a series of new reports that provides blood gas and electrolyte analyzers market statistics, including blood gas and electrolyte analyzers industry global market size, regional shares, competitors with a blood gas and electrolyte analyzers market share, detailed blood gas and electrolyte analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the blood gas and electrolyte analyzers industry. This blood gas and electrolyte analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Blood gas and electrolyte analyzers are utilized to measure combinations of pH, blood gases, electrolytes, and metabolite parameters from whole blood samples. Electrolytes are assessed in clinical laboratories using both serum and whole blood samples obtained for arterial blood gas (ABG) analysis.

The primary blood gas and electrolyte analyzer products include blood gas analyzers, electrolyte analyzers, combined analyzers, and consumables. Blood gas analyzers are used to measure blood gases, pH, electrolytes, and certain metabolites in whole blood specimens. They can determine pH, partial pressures of carbon dioxide and oxygen, and the concentrations of various ions and metabolites. Blood gas and electrolyte analyzers are available in different formats such as portable, laboratory, and benchtop models. These analyzers are employed by end-users including central laboratories, point-of-care settings, diagnostic centers, hospitals, and other healthcare facilities.

The blood gas and electrolyte analyzers market consist of sales of blood oxygen analyzer, full-automatic blood gas analyzer, tissue oxygen content measuring instrument, handheld blood gas analyzer, blood gas collector, semi-automatic electrolyte analyzer, potassium analyzer and fully automatic electrolyte analyzer. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.